Investigating USP42 Mutation as Underlying Cause of Familial Non-Medullary Thyroid Carcinoma
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25031522 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Elisabete Teixeira und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Signalling and Metabolism Group do Instituto de Investigação e Inovação em Saúde-i3s, Rua Alfredo Allen 208, 4200-135 Porto, Portugal. Hauptthemen laut MEDLINE: Thyroid Cancer, Papillary, Thyroid Neoplasms, Ubiquitin-Specific Proteases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, FCT–Fundação para a Ciência e a Tecnologia, Concurso de Projetos de I&D em Todos os Domínios Científicos—2022.
Abstract (Originalsprache)
In a family with Familial Non-Medullary Thyroid Carcinoma (FNMTC), our investigation using Whole-Exome Sequencing (WES) uncovered a novel germline USP42 mutation [p.(Gly486Arg)]. USP42 is known for regulating p53, cell cycle arrest, and apoptosis, and for being reported as overexpressed in breast and gastric cancer patients. Recently, a USP13 missense mutation was described in FNMTC, suggesting a potential involvement in thyroid cancer. Aiming to explore the USP42 mutation as an underlying cause of FNMTC, our team validated the mutation in blood and tissue samples from the family. Using immunohistochemistry, the expression of USP42, Caspase-3, and p53 was assessed. The USP42 gene was silenced in human thyroid Nthy-Ori 3-1 cells using siRNAs. Subsequently, expression, viability, and morphological assays were conducted. p53, Cyclin D1, p21, and p27 proteins were evaluated by Western blot. USP42 protein was confirmed in all family members and was found to be overexpressed in tumor samples, along with an increased expression of p53 and cleaved Caspase-3. siRNA-mediated USP42 downregulation in Nthy-Ori 3-1 cells resulted in reduced cell viability, morphological changes, and modifications in cell cycle-related proteins. Our results suggest a pivotal role of USP42 mutation in thyroid cell biology, and this finding indicates that USP42 may serve as a new putative target in FNMTC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Signalling and Metabolism Group do Instituto de Investigação e Inovação em Saúde-i3s, Rua Alfredo Allen 208, 4200-135 Porto, Portugal.
- Cancer Signalling and Metabolism Group do Instituto de Patologia e Imunologia Molecular da Universidade do Porto-Ipatimup, Rua Júlio Amaral de Carvalho 45, 4200-135 Porto, Portugal.
- Departamento de Biomedicina da Faculdade de Medicina da Universidade do Porto-FMUP, Alameda Prof. Hernâni Monteiro, 4200-319 Porto, Portugal.
- Departamento de Bioquímica da Faculdade de Ciências da Universidade do Porto-FCUP, Rua do Campo Alegre 1021 1055, 4169-007 Porto, Portugal.
- Departamento de Patologia e Imunologia Molecular do Instituto de Ciências Biomédicas Abel Salazar da Universidade do Porto-ICBAS, R. Jorge de Viterbo Ferreira 228, 4050-313 Porto, Portugal.
- Department of Pathology, Iuliu Haţieganu University of Medicine and Pharmacy, Municipal Clinical Hospital, Cluj-Napoca 400139, Romania.
ORCID-Profile: Elisabete Teixeira, Maria Bungărdean, Raquel T Lima, João Vinagre, Valdemar Máximo, Paula Soares
Förderung
- NCATS NIH HHS
- FCT–Fundação para a Ciência e a Tecnologia
- Concurso de Projetos de I&D em Todos os Domínios Científicos—2022
- Norte Portugal Regional Operational Programme (NORTE 2020)
Zitieren
APA
Teixeira, E., Fernandes, C., Bungărdean, M., Paula, A. D. C., Lima, R. T., Batista, R., Vinagre, J., Sobrinho-Simões, M., Máximo, V., & Soares, P. (2024). Investigating USP42 Mutation as Underlying Cause of Familial Non-Medullary Thyroid Carcinoma. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25031522
Vancouver
Teixeira E, Fernandes C, Bungărdean M, Paula ADC, Lima RT, Batista R, et al. Investigating USP42 Mutation as Underlying Cause of Familial Non-Medullary Thyroid Carcinoma. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25031522
BibTeX
@article{Teixeira2024,
author = {Teixeira, Elisabete and Fernandes, Cláudia and Bungărdean, Maria and Paula, Arnaud Da Cruz and Lima, Raquel T and Batista, Rui and Vinagre, João and Sobrinho-Simões, Manuel and Máximo, Valdemar and Soares, Paula},
title = {Investigating USP42 Mutation as Underlying Cause of Familial Non-Medullary Thyroid Carcinoma},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25031522}
}
EUVIMED